Analyst Briefing Presentation on the Global Oncology Biomarkers Market to Be Held On 18th May 2010

soft Word 11'>

The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Global oncology biomarkers market to be held on 18th May 2010.

The global oncology biomarker market is expected to grow from $4.1 billion in 2009 to $9.5 billion in 2014 at a CAGR of 18.1% from 2009 to 2014. The market is primarily driven by the strong government support and the increasing demand for personalized treatment, due to which technologies such as genomics and proteomics are gaining importance.

The oncology biomarkers market offers high-growth opportunities with numerous initiatives to encourage biomarker-based cancer treatment. Government agencies such as Food and Drug Administration (FDA) and the National Cancer Institute (NCI) have taken an active interest in the field, especially with the declining success to failure rate of oncology drugs.

The report segments the overall market for oncology biomarkers into the submarkets for biomarker-based cancer discovery and diagnostics. While the discovery market currently holds the larger market share, the diagnostic market is expected to have a higher CAGR. The biomarkers diagnostics market is dominated by Roche, which commands a 28% market share, followed by Gen-Probe, which holds a share of 18%.

This analyst briefing focuses on the global oncology biomarkers market over the period 2009-2014.The agenda for the briefing includes discussion on key high growth markets, marking the growth trend in biomarker discovery and diagnosis. The briefing will also cover the competitive scenario and the trends and opportunities in the geographic markets of North America, Europe, Asia, and ROW.

Browse the complete report on: Briefing:

Analyst Briefing Presentation on the Global Ophthalmology Devices Market

Analyst Briefing Presentation on the Global Smart Homes Market

Analyst Briefing on Wooing the Underbanked – Need, Behavior and Attitude Analysis

About us:

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website

Ms. Sunita
7557 Rambler road,
Suite727, Dallas, TX 75231
Tel: +1-888-989-8004

Customer comments

No comments were found for Analyst Briefing Presentation on the Global Oncology Biomarkers Market to Be Held On 18th May 2010. Be the first to comment!